Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
ACCD - Accolade, Inc.
Market Cap 1.09B P/E - EPS this Y 81.20% Ern Qtrly Grth -
Income -122.73M Forward P/E -10.21 EPS next Y 6.60% 50D Avg Chg 10.00%
Sales 388.49M PEG 8.63 EPS past 5Y - 200D Avg Chg 25.00%
Dividend N/A Price/Book 2.39 EPS next 5Y -0.90% 52W High Chg -15.00%
Recommedations 2.00 Quick Ratio 2.21 Shares Outstanding 77.41M 52W Low Chg 111.00%
Insider Own 2.99% ROA -9.70% Shares Float 69.64M Beta 2.08
Inst Own 86.33% ROE -26.66% Shares Shorted/Prior 3.14M/2.78M Price 14.40
Gross Margin 45.05% Profit Margin -31.59% Avg. Volume 646,991 Target Price 14.80
Oper. Margin -32.08% Earnings Date Apr 25 Volume 408,999 Change -3.87%
Healthcare | Health Information Services | United States
About Accolade, Inc.

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. It also provides medical opinion and decision support services; and technology and administrative services to the medical practice PCs providing virtual primary care services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.

Accolade, Inc. News
04:42 PM Accolade Inc (ACCD) Surpasses Revenue Expectations and Narrows Losses in Fiscal Q4 and Full ...
04:15 PM Accolade (ACCD) Reports Q4 Loss, Tops Revenue Estimates
03:14 PM Accolade: Fiscal Q4 Earnings Snapshot
03:03 PM Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024
04/03/24 Accolade to Announce Fiscal Fourth Quarter 2024 Financial Results
04/01/24 Recent uptick might appease Accolade, Inc. (NASDAQ:ACCD) institutional owners after losing 24% over the past year
03/21/24 Strength Seen in Paymentus (PAY): Can Its 7.8% Jump Turn into More Strength?
03/20/24 Accolade Wins 2024 Artificial Intelligence Excellence Award
03/19/24 Accolade Promotes Kelsi McDonald Harris to Chief People Officer
02/28/24 Accolade To Present at Upcoming Investor Conferences
02/27/24 Accolade Welcomes Brightline to Trusted Partner Ecosystem
02/23/24 20 Most Valuable Digital Health Companies In The US
02/07/24 Are Business Services Stocks Lagging Accolade (ACCD) This Year?
02/05/24 Does Accolade (ACCD) Have the Potential to Rally 25.58% as Wall Street Analysts Expect?
01/30/24 Zacks.com featured highlights include AxoGen, Western Digital, Accolade and Credo Technology Group
01/23/24 Accolade Welcomes Kindbody to Trusted Partner Ecosystem
01/19/24 Wall Street Analysts Predict a 26.85% Upside in Accolade (ACCD): Here's What You Should Know
01/19/24 Why Accolade (ACCD) Stock Might be a Great Pick
01/11/24 Accolade, Inc. (NASDAQ:ACCD) Q3 2024 Earnings Call Transcript
01/09/24 Q3 2024 Accolade Inc Earnings Call
ACCD Chatroom

User Image Jxcx1990 Posted - 6 hours ago

$ACCD what did they say in the call that the stock is dropping? Earning report was pretty good

User Image epsguid Posted - 7 hours ago

$ACCD reported a loss of $0.10, consensus was ($0.11), Earnings Whisper was ($0.04) via @eWhispers #whispermiss http://eps.sh/d/accd

User Image DonCorleone77 Posted - 7 hours ago

$ACCD Accolade reports Q4 EPS (10c), consensus (7c) Reports Q4 revenue $124.83M, consensus $123.91M. "Accolade has built a rare healthcare services business at scale with consistently strong growth rates. Whether serving consumers, employers, health plans, or government entities, the core of our value proposition is making healthcare easier to access, navigate, and consume for our members. We provide a unique blend of healthcare services and next generation technology that will further differentiate us in FY 2025 as we approach $500 million in revenues and forecast full year positive Adjusted EBITDA," said Rajeev Singh, Accolade Chair of the Board and Chief Executive Officer.

User Image Stock_Titan Posted - 7 hours ago

$ACCD Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024 https://www.stocktitan.net/news/ACCD/accolade-announces-results-for-fiscal-fourth-quarter-and-full-year-hj4v72x7wg9t.html

User Image insiderbuyingselling Posted - 6 days ago

$ACCD new insider selling: 109 shares. http://insiderbuyingselling.com/?t=ACCD

User Image chart_tradr Posted - 1 week ago

$ACCD Encouragin post on linkedin https://www.linkedin.com/feed/?highlightedUpdateUrn=urn%3Ali%3Aactivity%3A7186814256254738432

User Image chart_tradr Posted - 1 week ago

$ACCD Looking better in a red market day

User Image QueensChamber Posted - 1 week ago

$ACCD incredible drop since rising to 16+. Will need a decent ER now to stabilize the price, otherwise back down to 6’s I’d guess

User Image insiderbuyingselling Posted - 1 week ago

$ACCD new insider selling: 253 shares. http://insiderbuyingselling.com/?t=ACCD

User Image insiderbuyingselling Posted - 1 week ago

$ACCD new insider selling: 265 shares. http://insiderbuyingselling.com/?t=ACCD

User Image chart_tradr Posted - 2 weeks ago

@cheech1120 I have been watching these charts and price movements for several years...and always a mystery to predict...you can be right few times and then the next time you make another prediction and it crushes you...Like $ACCD - they beat top and bottom line and gave good guidance ..stock moved 3 dollars from 12 to 15 on the same day..stayed there for few days and now its trading at slightly below $9..From 15 to 9 just like that..with no news...and I was expecting it to go higher once it was in 10 dollar range..but no

User Image chart_tradr Posted - 2 weeks ago

$ACCD ACCD $10 Call 5/17 looks good for an earnings beat bet....at 55 cents

User Image Stock_Titan Posted - 3 weeks ago

$ACCD Accolade to Announce Fiscal Fourth Quarter 2024 Financial Results https://www.stocktitan.net/news/ACCD/accolade-to-announce-fiscal-fourth-quarter-2024-financial-tkug29imcuzy.html

User Image insiderbuyingselling Posted - 1 month ago

$ACCD new insider selling: 376 shares. http://insiderbuyingselling.com/?t=ACCD

User Image insiderbuyingselling Posted - 1 month ago

$ACCD new insider selling: 181 shares. http://insiderbuyingselling.com/?t=ACCD

User Image Stock_Titan Posted - 1 month ago

$ACCD Accolade Promotes Kelsi McDonald Harris to Chief People Officer https://www.stocktitan.net/news/ACCD/accolade-promotes-kelsi-mc-donald-harris-to-chief-people-s64uq0kcpnpm.html

User Image QueensChamber Posted - 1 month ago

$ACCD I guess it’s possible we see 7s again. Seems outrageous considering the last several beats but I guess here we are. Could be a rocky 2024. They need to get to profitability as advertised next year.

User Image insiderbuyingselling Posted - 1 month ago

$ACCD new insider selling: 662 shares. http://insiderbuyingselling.com/?t=ACCD

User Image chart_tradr Posted - 1 month ago

$ACCD If reversal is once again happening...how far could it go? 10.50?

User Image insiderbuyingselling Posted - 1 month ago

$ACCD new insider selling: 433 shares. http://insiderbuyingselling.com/?t=ACCD

User Image chart_tradr Posted - 1 month ago

$ACCD From 15 to low 9 in a month... What's next? Back to 6?

User Image insiderbuyingselling Posted - 1 month ago

$ACCD new insider selling: 485 shares. http://insiderbuyingselling.com/?t=ACCD

User Image Jxcx1990 Posted - 1 month ago

$ACCD what’s going on here? ER was very good and now it’s just back at where it was before ER

User Image DailyStocksPicks Posted - 1 month ago

Veradigm Inc. ($MDRX) appears oversold primarily due to its delisting from the Nasdaq due to non-compliance with listing rules, significantly impacting investor confidence and liquidity as trading moves to less regulated OTC markets. This situation is compounded by the company's strategic acquisition of ScienceIO for $140 million to enhance its AI capabilities, indicating a focus on long-term growth amidst financial and operational challenges. These factors, coupled with market volatility and the stock trading near its 52-week low, suggest a perception of oversold conditions, reflecting investor concerns over immediate financial stability versus long-term strategic moves​​​​​​. $SLP, $SMRT, $GB, $ACCD For more details https://youtu.be/QDW75yHzRo0

User Image Stock_Titan Posted - 02/28/24

$ACCD Accolade To Present at Upcoming Investor Conferences https://www.stocktitan.net/news/ACCD/accolade-to-present-at-upcoming-investor-dwl4y1by5bfo.html

User Image Stock_Titan Posted - 02/27/24

$ACCD Accolade Welcomes Brightline to Trusted Partner Ecosystem https://www.stocktitan.net/news/ACCD/accolade-welcomes-brightline-to-trusted-partner-c3834svsl7hr.html

User Image Ninja_Tradez Posted - 02/26/24

📢 $ACCD - Leerink Partners Initiates Coverage On Accolade with Outperform Rating, Announces Price Target of $16 https://newsfilter.io/a/2a175777247fda834f8186edb1487ce2

User Image Fullratio Posted - 2 months ago

Healthcare sector stocks with high YoY EPS growth in Q4 2023: $WBA $ACCD $ANGO

User Image InvestorPlace Posted - 2 months ago

Alabama's Fertility Ruling Raises Challenges for Stocks of Fertility Benefits Providers $PGNY $ACCD https://investorplace.com/2024/02/alabamas-fertility-ruling-raises-challenges-for-stocks-of-fertility-benefits-providers/

User Image MambaMentality077 Posted - 2 months ago

$ACCD looking weak. What's going on with this one?

Analyst Ratings
Stifel Buy Apr 22, 24
Leerink Partners Outperform Feb 26, 24
Needham Buy Jan 19, 24
Truist Securities Buy Jan 9, 24
Piper Sandler Overweight Jan 9, 24
Wells Fargo Equal-Weight Jan 9, 24
Raymond James Outperform Jan 9, 24
Stifel Buy Jan 4, 24
Piper Sandler Overweight Nov 22, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Eskew Richard EVP General Counsel EVP General Counsel Feb 01 Sell 11.59 562 6,514 37,195 02/05/24
McHugh Colin Chief Accounting Off.. Chief Accounting Officer Feb 01 Sell 11.59 424 4,914 35,426 02/05/24
Eskew Richard EVP General Counsel EVP General Counsel Jan 19 Sell 11.99 400 4,796 36,119 01/22/24
Cavanaugh Robert N President President Jan 16 Sell 12.86 186 2,392 170,086 01/18/24
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Jan 16 Sell 12.86 383 4,925 742,711 01/18/24
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Jan 16 Sell 12.86 146 1,878 176,102 01/18/24
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Jan 11 Sell 15.02 21,530 323,381 742,162 01/12/24
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Jan 11 Option 4.2 21,530 90,426 763,692 01/12/24
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Jan 10 Sell 14.75 770 11,358 742,162 01/12/24
Cavanaugh Robert N President President Jan 10 Sell 14.75 255 3,761 169,762 01/12/24
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Jan 10 Sell 14.75 267 3,938 175,833 01/12/24
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Jan 09 Option 4.2 103,470 434,574 808,553 01/11/24
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Jan 09 Sell 15.02 103,470 1,554,119 741,282 01/11/24
Eskew Richard EVP General Counsel EVP General Counsel Jan 02 Sell 11.4 590 6,726 36,519 01/04/24
McHugh Colin Chief Accounting Off.. Chief Accounting Officer Jan 02 Sell 11.4 446 5,084 34,617 01/04/24
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Dec 18 Sell 10.89 116 1,263 175,330 12/20/23
Cavanaugh Robert N President President Dec 18 Sell 10.89 151 1,644 169,307 12/20/23
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Dec 18 Sell 10.89 366 3,986 741,282 12/20/23
Eskew Richard EVP General Counsel EVP General Counsel Dec 19 Sell 10.76 400 4,304 35,470 12/20/23
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Dec 11 Sell 9.23 677 6,249 740,715 12/13/23
Cavanaugh Robert N President President Nov 16 Sell 7.94 149 1,183 168,086 11/20/23
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Nov 16 Sell 7.94 358 2,843 739,742 11/20/23
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Nov 16 Sell 7.94 114 905 145,713 11/20/23
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Nov 10 Sell 6.99 223 1,559 145,413 11/14/23
Cavanaugh Robert N President President Nov 10 Sell 6.99 217 1,517 167,724 11/14/23
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Nov 10 Sell 6.99 666 4,655 739,166 11/14/23
Eskew Richard EVP General Counsel EVP General Counsel Nov 01 Sell 6.88 456 3,137 33,932 11/03/23
McHugh Colin Chief Accounting Off.. Chief Accounting Officer Nov 01 Sell 6.88 345 2,374 32,952 11/03/23
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Oct 16 Sell 7.22 118 852 144,866 10/18/23
Cavanaugh Robert N President President Oct 16 Sell 7.22 153 1,105 167,231 10/18/23
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Oct 16 Sell 7.22 371 2,679 588,183 10/18/23
Cavanaugh Robert N President President Sep 18 Sell 11.81 157 1,854 166,378 09/20/23
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Sep 18 Sell 11.81 121 1,429 144,019 09/20/23
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Sep 18 Sell 11.81 378 4,464 586,630 09/20/23
Eskew Richard EVP General Counsel EVP General Counsel Sep 01 Sell 13.53 475 6,427 31,596 09/06/23
McHugh Colin Chief Accounting Off.. Chief Accounting Officer Sep 01 Sell 13.53 358 4,844 31,199 09/06/23
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Aug 17 Sell 13.03 121 1,577 143,177 08/21/23
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Aug 17 Sell 13.03 377 4,912 585,087 08/21/23
Cavanaugh Robert N President President Aug 17 Sell 13.03 157 2,046 165,529 08/21/23
Eskew Richard EVP General Counsel EVP General Counsel Aug 01 Sell 14.37 489 7,027 30,432 08/03/23
McHugh Colin Chief Accounting Off.. Chief Accounting Officer Aug 01 Sell 14.37 370 5,317 30,325 08/03/23
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Jul 17 Sell 14.16 117 1,657 142,336 07/19/23
Cavanaugh Robert N President President Jul 17 Sell 14.16 152 2,152 164,683 07/19/23
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Jul 17 Sell 14.16 364 5,154 583,538 07/19/23
SINGH RAJEEV Chief Executive Offi.. Chief Executive Officer Jul 10 Sell 12.68 655 8,305 582,970 07/12/23
Cavanaugh Robert N President President Jul 10 Sell 12.68 216 2,739 164,325 07/12/23
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Jul 10 Sell 12.68 222 2,815 142,039 07/12/23
Eskew Richard EVP General Counsel EVP General Counsel Jul 03 Sell 12 515 6,180 29,282 07/06/23
Barnes Stephen H. Chief Financial Offi.. Chief Financial Officer Jun 12 Sell 13.81 2,576 35,575 141,197 06/14/23
Cavanaugh Robert N President President Jun 12 Sell 13.81 2,511 34,677 163,478 06/14/23